UBS Group’s Medicus Pharma Warrant MDCXW Stock Holding History

UBS Group’s Portfolio MDCXW Stock Details MDCXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.43K	Buy	2,203 +738	+50%	+$341	﹤0.01%	9557
2026 Q1	$820	Buy	+1,465	New	+$1.2K	﹤0.01%	9725
2025 Q2	–	Sell	-2,299	Closed	-$1.61K	–	11061
2025 Q1	$1.61K	Buy	2,299 +299	+15%	+$310	﹤0.01%	9477
2024 Q4	$702	Buy	+2,000	New	+$1.28K	﹤0.01%	9397

Other funds holding MDCXW

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return

UBS Group's MDCXW Position: Q2 2026 in Review

UBS Group increased its Medicus Pharma Warrant (MDCXW) stake by 50% in Q2 2026, buying an estimated $341 and bringing the position to 2,203 shares worth $1.43K. The position accounts for ﹤0.01% of the portfolio, ranked #9557.

UBS Group first reported a position in MDCXW in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.61K in Q1 2025. 4 funds tracked by Wall St. Rank hold MDCXW as of Q2 2026.

UBS Group held 2,203 shares of Medicus Pharma Warrant worth $1.43K as of Q2 2026.
UBS Group bought 738 Medicus Pharma Warrant shares in Q2 2026, an estimated $341.
Medicus Pharma Warrant made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #9557 holding.
UBS Group first reported a position in Medicus Pharma Warrant in Q4 2024 and has held it in 4 quarters since.
UBS Group's Medicus Pharma Warrant position peaked at $1.61K in Q1 2025.
4 funds tracked by Wall St. Rank held Medicus Pharma Warrant as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.